Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel

Intravesical delivery of rapamycin via folate-modified liposomes dispersed in thermo-reversible hydrogel

Ho Yub Yoon,1,* In Ho Chang,2,* Yoon Tae Goo,1 Chang Hyun Kim,1 Tae Hoon Kang,1 Soo-Yeon Kim,3 Sang Jin Lee,3 Seh Hyon Song,4 Young Mi Whang,2 Young Wook Choi1 1College of Pharmacy, Chung-ang University, Seoul, Korea; 2College of Medicine, Chung-ang University, Seoul, Korea; 3Research Insti...

Full description

Bibliographic Details
Main Authors:	Yoon HY, Chang IH, Goo YT, Kim CH, Kang TH, Kim SY, Lee SJ, Song SH, Whang YM, Choi YW
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-08-01
Series:	International Journal of Nanomedicine
Subjects:	bladder cancer prolonged retention enhanced uptake antitumor efficacy autophagy mTOR signaling
Online Access:	https://www.dovepress.com/intravesical-delivery-of-rapamycin-via-folate-modified-liposomes-dispe-peer-reviewed-article-IJN

Similar Items

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
by: James T. Murray, et al.
Published: (2018-05-01)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
by: Won Seop Kim
Published: (2011-06-01)

Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis
by: Fen Zhang, et al.
Published: (2023-10-01)

Ginsenoside PPD’s Antitumor Effect via Down-Regulation of mTOR Revealed by Super-Resolution Imaging
by: Bo Teng, et al.
Published: (2017-03-01)

The mechanism of mTOR (mammalian target of rapamycin) in a mouse model of polycystic ovary syndrome (PCOS)
by: Yaba Aylin, et al.
Published: (2012-11-01)

Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy
by: Wei Zhao, et al.
Published: (2023-06-01)

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives
by: Olivier Dormond, et al.
Published: (2011-05-01)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
by: Junfang Yan, et al.
Published: (2021-01-01)

Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
by: Alessandro Bitto, et al.
Published: (2016-08-01)

Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial
by: Cabrera-López Cristina, et al.
Published: (2012-11-01)

Does Lymphovenous Anastomosis Effect Mammalian Target of Rapamycin Inhibitor-associated Lymphedema Patients?
by: Inah Yoon, et al.

Gastric Mammalian Target of Rapamycin Signaling Contributes to Inhibition of Ghrelin Expression Induced by Roux-En-Y Gastric Bypass
by: Danjie Li, et al.
Published: (2018-11-01)

Metabolic Effects on Mouse Embryonic Stem Cells and the Canonical Mammalian Target of Rapamycin Pathway
by: Bibiana Correia, et al.
Published: (2023-11-01)

Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01)

Therapeutic Effect of Rapamycin on Aortic Dissection in Mice
by: Makiko Hayashi-Hori, et al.
Published: (2020-05-01)

Melatonin regulates the ovarian function and enhances follicle growth in aging laying hens via activating the mammalian target of rapamycin pathway
by: Er-ying Hao, et al.
Published: (2020-04-01)

Immunomodulatory and Antiaging Mechanisms of Resveratrol, Rapamycin, and Metformin: Focus on mTOR and AMPK Signaling Networks
by: Vincenzo Sorrenti, et al.
Published: (2022-07-01)

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model
by: Wang Cun, et al.
Published: (2012-05-01)

A pulse rapamycin therapy for infantile spasms and associated cognitive decline
by: Emmanuel Raffo, et al.
Published: (2011-08-01)

Antarctic krill extracts enhance muscle regeneration and muscle function via mammalian target of rapamycin regulation
by: Seongmin Lee, et al.
Published: (2023-04-01)

Rapamycin Promotes ROS-Mediated Cell Death via Functional Inhibition of xCT Expression in Melanoma Under γ-Irradiation
by: Yunseo Woo, et al.
Published: (2021-04-01)

Mammalian target of rapamycin inhibitors: A paradigm shift in current immunosuppression protocols
by: Indranil Ghosh, et al.
Published: (2016-01-01)

Antiepileptic Effect and Safety Profile of Rapamycin in Pediatric Patients With Tuberous Sclerosis Complex
by: Krzysztof Sadowski, et al.
Published: (2022-04-01)

Rapamycin-Loaded Lipid Nanocapsules Induce Selective Inhibition of the mTORC1-Signaling Pathway in Glioblastoma Cells
by: Delphine Séhédic, et al.
Published: (2021-02-01)

Effects of dietary leucine supplementation on the gene expression of mammalian target of rapamycin signaling pathway and intestinal development of broilers
by: Yinlian Chang, et al.
Published: (2015-12-01)

Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
by: Aleksandra Derwich, et al.
Published: (2023-03-01)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
by: Luise Spormann, et al.
Published: (2020-07-01)

Mechanistic target of rapamycin signaling in human nervous system development and disease
by: Marie Girodengo, et al.
Published: (2022-09-01)

Rapamycin Promotes the Expansion of Myeloid Cells by Increasing G-CSF Expression in Mesenchymal Stem Cells
by: Minghao Li, et al.
Published: (2022-03-01)

Melatonin and Rapamycin Attenuate Isoflurane-Induced Cognitive Impairment Through Inhibition of Neuroinflammation by Suppressing the mTOR Signaling in the Hippocampus of Aged Mice
by: Hui Yuan, et al.
Published: (2019-11-01)

Effect of mechanistic/mammalian target of rapamycin complex 1 on mitochondrial dynamics during skeletal muscle hypertrophy
by: Kazuki Uemichi, et al.
Published: (2021-03-01)

Role for Target of Rapamycin (mTOR) Signal Pathway in Regulating Neuronal Injury after Intracerebral Hemorrhage
by: Jie-Ping Wang, et al.
Published: (2017-01-01)

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives
by: Seraina Faes, et al.
Published: (2021-03-01)

Rapamycin-induced hyperglycemia is associated with exacerbated age-related osteoarthritis
by: Dennis M. Minton, et al.
Published: (2021-10-01)

Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis
by: Min Li, et al.
Published: (2019-02-01)

Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
by: Jing eJiang, et al.
Published: (2013-08-01)

Prospects and hot spots for mammalian target of rapamycin in the field of neuroscience from 2002 to 2021
by: Lijun Li, et al.
Published: (2022-09-01)

The protective effects of rapamycin on cell autophagy in the renal tissues of rats with diabetic nephropathy via mTOR-S6K1-LC3II signaling pathway
by: Lei Liu, et al.
Published: (2018-10-01)

Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy
by: Jianya Huan, et al.
Published: (2022-03-01)

Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics
by: Zofia Chrienova, et al.
Published: (2022-12-01)